{"schema_version":"secwatch.filing_event.v1","accession":"0001728117-26-000042","form_type":"8-K","ticker":"GOSS","cik":"0001728117","company_name":"Gossamer Bio, Inc.","filed_at":"2026-06-04T21:34:07+00:00","discovered_at":"2026-06-05T10:05:00.215373+00:00","generated_at":"2026-06-05T10:10:44.129014+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Gossamer Bio shareholders re-elect directors, ratify EY, approve say-on-pay","bullets":["Faheem Hasnain re-elected as Class II director with 92.3M for, 26.7M withheld, 45.5M broker non-votes.","Russell Cox re-elected as Class II director with 89.0M for, 30.0M withheld, 45.5M broker non-votes.","Ratification of Ernst & Young as auditor for FY2026 passed: 163.2M for, 1.2M against, 41K abstain.","Advisory vote on named executive officer compensation approved: 111.3M for, 7.5M against, 137K abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001728117-26-000042","json":"https://secwatch.observer/filing/0001728117-26-000042.json","markdown":"https://secwatch.observer/filing/0001728117-26-000042.md","text":"https://secwatch.observer/filing/0001728117-26-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000042/0001728117-26-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000042/goss-20260604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T10:10:44.129014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"20f91f8be4c60ca04c51bc9ce30cb9dc6565b8c1","claim":"Gossamer Bio, Inc. shareholders approved Advisory approval of the compensation of the Company's named executive officers.","evidence_excerpt":"The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated: For Against Abstain Broker Non-Votes 111,286,550 7,545,502 137,461 45,450,098","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000042/0001728117-26-000042-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"93af3578ceae559ec2161fc6b422bfafec053705","claim":"Gossamer Bio, Inc. shareholders approved Election of two Class II directors for a three-year term to expire at the 2029 annual meeting.","evidence_excerpt":"The following two Class II directors were re-elected by the votes indicated: For Withheld Broker Non-Votes Faheem Hasnain 92,301,637 26,667,876 45,450,098 Russell Cox 88,975,980 29,993,533 45,450,098","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000042/0001728117-26-000042-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"f7c3d42d93f5a1c54b840fa4440cd6390fe1c4e3","claim":"Gossamer Bio, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","evidence_excerpt":"The selection was ratified by the votes indicated: For Against Abstain Broker Non-Votes 163,185,993 1,192,448 41,170 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000042/0001728117-26-000042-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}